Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 138 entries
View as:

Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02875080 Org: User:
Start: 09/27/16 End: 11/27/16 Due: 11/27/17

Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT03254108 Org: User:
Start: 11/06/17 End: 04/24/18 Due: 04/24/19

Samtasu Post-marketing General Drug Use-results Survey in Patients with Volume Overload in Heart Failure.

Phase: N/A Priority: Normal
NCT ID: NCT05712746 Org: User:
Start: 03/03/23 End: 05/31/26 Due: 05/31/27

A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01942148 Org: User:
Start: 08/31/10 End: 11/30/15 Due: 11/30/16

Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00233363 Org: User:
Start: 04/15/05 End: 01/27/06 Due: 01/27/07

A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT04784442 Org: User:
Start: 03/24/21 End: 05/17/22 Due: 05/17/23

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00876343 Org: User:
Start: 03/31/09 End: 07/31/12 Due: 07/31/13

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05372653 Org: User:
Start: 05/23/22 End: 11/29/23 Due: 11/29/24

A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05326347 Org: User:
Start: 05/31/22 End: 09/30/25 Due: 09/30/26

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02105272 Org: User:
Start: 04/30/14 End: 03/31/15 Due: 03/31/16

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Phase: N/A Priority: Normal
NCT ID: NCT00606281 Org: User:
Start: 01/31/08 End: 11/30/10 Due: 11/30/11

A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT01440920 Org: User:
Start: 09/30/11 End: 07/31/13 Due: 07/31/14

A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00317369 Org: User:
Start: 05/31/06 End: 08/31/07 Due: 08/31/08

Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD

Phase: N/A Priority: Normal
NCT ID: NCT02847624 Org: User:
Start: 03/24/14 End: 09/20/22 Due: 09/20/23

A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02088697 Org: User:
Start: 12/31/13 End: 01/31/14 Due: 01/31/15

A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00524498 Org: User:
Start: 09/30/07 End: 01/31/10 Due: 01/31/11

A Long-term Trial of EB-1020 in Adult Patients With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT06926829 Org: User:
Start: 07/31/25 End: 12/31/27 Due: 12/31/28

A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01631812 Org: User:
Start: 12/31/06 End: 02/28/10 Due: 02/28/11

A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03737474 Org: User:
Start: 10/04/18 End: 04/13/21 Due: 04/13/22

A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00537485 Org: User:
Start: 09/30/07 End: 12/31/09 Due: 12/31/10

Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT03620981 Org: User:
Start: 08/20/18 End: 05/15/23 Due: 05/15/24

A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02334787 Org: User:
Start: 01/31/15 End: 02/28/15 Due: 02/28/16

A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edema

Phase: N/A Priority: Normal
NCT ID: NCT01050530 Org: User:
Start: 12/31/09 End: 02/29/12 Due: 02/28/13

A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01628848 Org: User:
Start: 08/31/06 End: 04/30/08 Due: 04/30/09

A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00989573 Org: User:
Start: 10/31/09 End: 08/31/12 Due: 08/31/13